Serological evidence of exposure to Rickettsia felis and Rickettsia typhi in Australian veterinarians by Yen Thon Teoh et al.
RESEARCH Open Access
Serological evidence of exposure to
Rickettsia felis and Rickettsia typhi in
Australian veterinarians
Yen Thon Teoh1* , Sze Fui Hii2, Mark A. Stevenson1, Stephen Graves2, Robert Rees3, John Stenos2
and Rebecca J. Traub1
Abstract
Background: Rickettsia felis and Rickettsia typhi are emerging arthropod-borne zoonoses causing fever and flu-like
symptoms. Seroprevalence and risk factors associated with exposure to these organisms was explored in Australian
veterinarians.
Methods: One hundred and thirty-one veterinarians from across Australia were recruited to participate in a cross-
sectional survey. Veterinarians provided a single blood sample and answered a questionnaire on potential risk
factors influencing their exposure to R. felis and R. typhi. Indirect microimmunofluorescence antibody testing (IFAT)
was used to identify evidence of serological exposure of the participants to R. felis and R. typhi. Results were
analyzed and a logistical regression model performed to predict risk factors associated with seropositivity.
Results: In total, 16.0% of participants were seropositive to R. felis, 4.6% to R. typhi and 35.1% seropositive to both,
where cross-reactivity of the IFAT between R. felis and R. typhi precluded a definitive diagnosis. Veterinarians
residing within the south-eastern states of Victoria and Tasmania were at a higher risk of exposure to R. felis or
generalised R. felis or R. typhi exposure. Older veterinarians and those that recommended flea treatment to their
clients were found to be significantly protected from exposure.
Conclusions: The high exposure to R. felis amongst veterinary professionals suggests that flea-borne spotted fever
is an important cause of undifferentiated fever conditions that may not be adequately recognized in Australia.
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Background
Rickettsia felis is a bacterial pathogen and the etiological
agent of flea-borne spotted fever (FBSF) or cat flea ty-
phus, cases of which have been described in many parts
of the world including Europe [1], the Americas [2], Asia
[3] and Oceania [4]. Human infection results from trans-
mission through an infected arthropod vector, typically
fleas infecting a bite site with rickettsiae; the resulting in-
fection is typically characterized by a series of non-specific
symptoms including pyrexia, maculopapular rash, eschar,
myalgia, arthralgia, headache and fatigue [5].
The biological vector for R. felis is the cat flea, Cteno-
cephalides felis [6], although it has also been found in
other arthropods. Rickettsiae are generally maintained
within reservoir hosts, typically mammals, and their as-
sociated arthropod vectors [7]. Efforts to identify a verte-
brate biological reservoir for R. felis have so far remained
unresolved. While R. felis DNA has been detected in cat
[8], dog [9] and opossum [10] blood, successful culture of
the organism from mammalian blood has yet to be
achieved. In C. felis, R. felis is maintained for up to 12 gen-
erations in the absence of a blood meal [11].
A number of rickettsial organisms have been described
in Australia, including Rickettsia australis (causing
Queensland tick typhus), Rickettsia honei (causing Flin-
ders Island spotted fever), Rickettsia honei marmionii
(causing Australian spotted fever), Rickettsia typhi
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(causing murine typhus), Orientia tsutsugamushi (caus-
ing scrub typhus) and Coxiella burnetti (causing Q fever)
[12]. Each can cause fever and flu-like symptoms, are
spread by the bite of an infected arthropod and interact
with Australian wildlife in sylvatic cycles. Some species,
such as R. typhi, display serological cross-reactivity with
R. felis, presenting a diagnostic challenge requiring con-
current testing against both R. felis and R. typhi antigen
to establish an aetiology [4]. Of the R. felis-like species,
the URRWXCal2 (Cal2) variant is predominant in C.
felis felis fleas in Australia [13].
Pet ownership is widespread in Australia, with dog
and cat ownership estimated at 36% and 23% respect-
ively [14]. Dogs in particular have been implicated in po-
tentially contributing to the life-cycle of R. felis, with
molecular detection of the R. felis ompB gene in the
blood of 9% of pound dogs in south east Queensland
[15] and 2.3% of indigenous community dogs in the
Northern Territory [13]. Both dogs and cats are well
known to harbor ectoparasites, with C. felis felis being
the dominant flea species [16], from which R. felis has
also been isolated [17, 18].
The first reported Australian cases of R. felis occurred
in Victoria [19] in a family living in metropolitan Mel-
bourne, Victoria, that had received two flea-ridden kit-
tens from a farm in Lara, Victoria. Since then, multiple
other clinical cases of human infection in patients in
New South Wales, Queensland, South Australia, Tas-
mania and Western Australia have been confirmed [4].
Risk factors for exposure to R. felis however were not
described. In a seroepidemiological study in Spain, R.
felis infection was associated with high risk occupations
involving working outdoors, contact with animals or po-
tential contact with rodents [20]. In Colombia, gender,
home location and age were associated with R. felis ex-
posure [21].
In small animal clinical practice, exposure to flea-
ridden animals is a potential occupational hazard for
veterinarians. Approximately 10,000 veterinarians are
employed in Australia [22], a proportion of whom will
have contact with animals as part of their job. Due to
this potential, veterinarians of Australia are the focus of
this study which aims to determine the seroprevalence
and risk factors for exposure R. felis.
Methods
Participant selection
Veterinarians (n = 131) were recruited at the Australian
Veterinary Association Pan-Pacific conference held in
Brisbane (May, 2015) and at the University of Mel-
bourne (December, 2015). Selection was opportunistic,
with consenting healthy individuals invited to answer a
questionnaire and provide a blood sample on a voluntary
basis. Serology testing results were made available to the
participants.
Survey
A questionnaire was designed to collect information
from participants on personal demographics and poten-
tial risk factors contributing to R. felis infection; this in-
cluded age, gender, location, potential for exposure to
different animals in the workplace and at home, know-
ledge on R. felis, attitudes towards flea control in com-
panion animals and any recent disease symptoms.
Responses were digitalized, reversibly de-identified, and
stored on a password protected computer.
Blood sample collection
Samples were collected by either a registered medical
professional (doctor or nurse) or a certified venepunc-
turist. Approximately 8 ml of blood was taken from the
median cubital vein into serum separator tubes which
underwent centrifugation at 4000× g for 5 min, and the
separated sera stored at -20 °C until processed.
Culture to obtain antigen
Antigen culture and IFAT was performed at the Austra-
lian Rickettsial Reference Laboratory, Geelong, Australia.
The L929 cell line was selected to establish culture of
the rickettsial organisms tested in this study. Once a
confluent monolayer was achieved, live R. felis and R.
typhi cultures were revived from -80 °C and used to in-
fect separate flasks. Leibovitz-15 media (GIBCO, Rock-
ville, MD, USA) supplemented with 10% foetal calf
serum, 2 mM L-glutamine and 5% tryptose phosphate
broth was used to maintain R. felis. RPMI media
(GIBCO), supplemented with 10% foetal calf serum and
2 mM L-glutamine was used to maintain R. typhi. Infec-
tion levels were monitored using a semi-quantitative
qPCR, with species confirmation verified using PCR and
DNA sequencing (Australian Genomic Research Facility
Ltd., Australia); both molecular techniques were based
on the citrate synthase (gltA) gene [23].
Infected cell monolayers were harvested by physical
detachment and heat inactivated at 56 °C for 30 min.
Differential centrifugation at 3000× g for 10 min at room
temperature was used to separate the host cell material
from the rickettsiae; this pelleted Rickettsia was then re-
suspended in PBS.
Immunofluorescence antibody testing
The reference method for the diagnosis of R. felis infec-
tion is the indirect microimmunofluorescence antibody
test (IFAT), a serological test detecting antibodies devel-
oped after exposure. Due to shared epitopes, some of
which may have been gained from horizontal gene trans-
fer [24], serological cross-reactivity is often noted
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between R. felis, widely considered to be a spotted fever
group (SFG) or transitional group Rickettsia, with others
from the closely related typhus group (TG), such as R.
typhi [25].
Working concentrations of rickettsial antigen were de-
termined by comparing the fluorescence of serial doub-
ling dilutions of R. felis and R. typhi on the IFAT.
Rickettsial antigen of R. felis and R. typhi was spotted on
40-well slides (Scientific Device Laboratory, Des Plaines,
IL, USA), air-dried and fixed in 100% acetone for 2 min.
Serum samples were diluted in 2% casein in PBS at
1:128, and 2-fold serial dilutions we prepared onward as
required until the end-point titer was determined. Posi-
tive and negative controls were included in each assay
run. Slides were incubated at 35 °C for 40 min in a hu-
midified environment, washed in 1/10 PBS, and air-
dried. A fluoresceinisothiocyanate (FITC)-labelled goat
anti-human immunoglobulin IgG (H + L) (Kirkegaard &
Perry Laboratories, Gaithersburg, USA) diluted at 1:1000
was then spotted on each well, and slides incubated for a
further 35 °C for 40 min. Following the final washing,
the slides were air-dried, covered and stored in a dark
environment at 4 °C until read.
Each well was visualized by fluorescence microscopy
to the end-point dilution, with a minimum dilution of
1:128 required to deem a sample as reactive. Readings
were repeated by a second independent observer to con-
trol bias, with a third independent observer recruited to
resolve any discrepancies.
Exponentially increasing dilutions were standardized
to a linear scale and rickettsial exposure definitively at-
tributed to participants with a preferential serological re-
activity at a minimum four-fold dilution difference
against one organism compared to the other. Patient
samples that tested within this limit were not allocated
to a group and were thus classified as indeterminate
samples representing mixed infections, reactivity from
other related rickettsiae or older infections with lower
serological reactivities.
Data analysis
Results were entered and collected using a spreadsheet
application (Libreoffice calc). R statistics software was
used to read and analyze the data. Animal exposures
were grouped into categories (companion, large and
exotic) and location was designated metropolitan or
rural based on distance of the participant from the
centre of a major city (50 km from Sydney, Melbourne,
Brisbane, 40 km from Perth, Adelaide, 30 km from
Canberra, Hobart, Darwin). The distribution of the par-
ticipants was compared with that previously determined
by the Australian Bureau of Statistics (ABS) in 2015
[22].
Exploratory analyses were performed using the epiR
and epitools packages, with comparisons made between
patients serologically testing preferentially to R. felis or
R. typhi, as well as a category for general rickettsial re-
activity including either preferentially reactive sera as
well as indeterminate sera. Univariate analyses using
probability ratio analyses were compiled from informa-
tion on risk factors as determined by the questionnaire,
and biological risk factors meeting the odds-ratio criteria
with a P-value less than 0.2 were selected for inclusion
in the multivariate model. Models were developed using
the glm function by backwards elimination based on po-
tential risk factors identified in the exploratory data ana-
lysis. Graphics were generated using the ggplot2 package,
with map data from the GADM database.
Results
A total of 131 veterinarians were recruited for this study
(Fig. 1), with a distribution based on age and state ap-
proximately representative of the distribution of veteri-
narians across Australia (Fig. 2) with the exception of
the Northern Territory, from which no veterinarians
were recruited. Younger participants (20–39 years) and
middle-aged participants (40–59 years), on average,
spent more hours in private practice (22 and 24 h per
week, respectively) compared with 17.5 h per week for
older participants.
Awareness of R. felis and its associated zoonotic risk
was assessed, with only 72 of 127 (55.8%) veterinarians
who recorded a response to this question stated they
were aware of the organism. While the majority of the
127 respondents to the question (122 or 96.1%) were of
the opinion that fleas posed a risk to animals, only 65
(51.2%) thought that fleas also posed a risk to humans.
Of the 73 Rickettsia-exposed positive participants, 27 of
71 respondents (38.0%) recorded no recent (within the
last 3 months) flea bites.
IFAT attributed twenty-one (16.0%) participants to R.
felis exposure and six (4.6%) to R. typhi exposure from a
specifically preferential reaction to the respective anti-
gen. Forty-six (35.1%) veterinarians had a serological re-
action to either antigen at a level which was within two
serial dilutions to one another, and so a diagnosis was
not able to be definitively made based solely on serology.
Fifty-eight (44.3%) tested negative by IFAT, suggesting
no recent exposure to either organism.
Risk factors
Univariate analyses indicated that sex, metropolitan/
rural location and outdoor activity were not significant
for exposure to R. felis P > 0.2. Exposure to companion
animals was not a significant predictor of R. felis expos-
ure when tested in isolation (P = 1; OR: 1.27, 95% CI:
0.25–6.55). A confounding influence from flea-treatment
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was noted with Mantel-Haenszel testing: [t = 0.006, P =
0.938 (OR (crude): 1.26, 95% CI: 0.24–6.49; OR (M-H):
1.91, 95% CI: 0.35–10.31; crude: M-H: 0.66)]. Once ad-
justed, a non-significant but stronger trend was observed
amongst veterinarians that had contact with companion
animals whilst concurrently not treating their own ani-
mals for fleas (P = 0.5; OR: 1.81, 95% CI: 0.43–7.64). Fur-
ther non-significant positive trends were observed for
reported disease symptoms (including rashes, headaches
and fevers) potentially associated with rickettsial
exposure.
Multivariate logistical regression converged for data on R.
felis or R. typhi (including indeterminate) infection and R.
felis infection is displayed in Tables 1 and 2; analysis on the
R. typhi subset was not successful in producing a model
due to low numbers of positives within our study popula-
tion (Table 3). Participants were divided into categories ac-
cording to age (20–39, 40–59 (reference category), 60+
years) and region [southeast including Victoria and Tas-
mania, northeast including Queensland, east including New
South Wales and Canberra and south/west including West-
ern Australia and South Australia (reference category)].
Older veterinarians above the age of 60 were at a signifi-
cantly decreased risk of exposure to R. felis (t = -2.095, P =
0.04; OR: 0.756, 95% CI: 0.582–0.982) or generalized R. felis
or R. typhi exposure (t = -2.147, P = 0.034; OR: 0.752, 95%
CI: 0.579–0.975). Veterinarians recommending flea treat-
ments to clients were also at a significantly decreased risk
of exposure to generalized R. felis or R. typhi exposure (t
= -2.034, P = 0.044; OR: 0.611, 95% CI: 0.38–0.982).
Conversely, participants working in the southeastern Aus-
tralian states of Victoria or Tasmania were at an increased
risk of R. felis exposure (t = 1.808, P = 0.075; OR: 1.381, 95%
CI: 0.973–1.96).
Discussion
This study is the first to demonstrate natural exposure
to R. felis in 16.0%, R. typhi in 4.6% and potential expos-
ure to either or both in a further 35.1% of Australian
veterinarians. This builds upon the evidence that human
exposure, as demonstrated in earlier studies in Spain
[20] and Colombia [21], where R. felis is ubiquitous in
areas where R. felis Cal2 has been detected in fleas, not-
ably C. felis felis. Infection with R. felis in Australia has
been previously reported in 20% of companion animal
fleas in Brisbane, Sydney and Melbourne [17] and up to
36% in regional centers in Western Australia [18]. Veter-
inarians in clinical practice are regularly exposed to ani-
mals, particularly companion animals (cats and dogs),
which may act as potential hosts for ectoparasites.
Trends were also seen when observing R. felis and R.
typhi reactive participants in combination, which is not
surprising as both organisms share vectors and hosts [2].
In this study, R. felis exposure was noted across each
of the Australian states tested with proportionally the
highest participant count from Victoria. We were able to
demonstrate an increased likelihood of exposure in vet-
erinarians working within the states of Victoria and Tas-
mania (β = 0.323; SE = 0.179; t = 1.808; P = 0.075). Both
are coastal south-eastern states and have a temperate
Fig. 1 Map of exposures and their associated serological testing exposures
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Table 1 Multivariate risk factor analysis of exposure to Rickettsia felis or R. typhi
Population Exposed Coefficient (SE) t P OR (95% CI)
Constant 0.993 (0.291) 3.41 0.001
Age
20–39 years 64 42 0.106 (0.101) 1.051 0.295 1.112 (0.912–1.356)a
40–59 years 42 24 Reference
60+ years 23 6 -0.285 (0.133) -2.147 0.034 0.752 (0.579–0.975)
State
SA or WA 12 5 Reference
NSW or ACT 33 16 -0.040 (0.163) -0.244 0.808 0.961 (0.698–1.323)
QLD 22 10 -0.046 (0.175) -0.263 0.793 0.955 (0.678–1.346)
VIC or TAS 55 36 0.093 (0.157) 0.591 0.555 1.097 (0.807–1.493)
Recommends flea treatment to clients
No 5 5 Reference
Yes 123 66 -0.493 (0.242) -2.034 0.044 0.611 (0.38–0.982)
Abbreviations: CI confidence interval, OR odds ratio, SE standard error
aInterpretation: compared with participants from the reference category (those between the ages of 40–59), after adjusting for the effect of location (state) and
whether they recommended flea treatment to clients, participants aged 60+ had a 1.330 (0.752-1; CI: 1.026–1.727) times lower odds of exposure
Fig. 2 Comparisons of study participants to veterinary population as gathered by the Australian Bureau of Statistics (ABS)
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climate. While state-based flea infection rates of R. felis
have not been thoroughly investigated within Australia,
it may be a reflection of higher R. felis-flea infection
rates in these cooler climates, as reported previously in
other parts of the world [26]. It should be noted that this
study was centered on metropolitan areas, whereas pre-
vious studies on R. felis infection rates in Australia com-
pared rural and metropolitan flea populations [9, 18].
While epizoonotic associations are typically ob-
served in areas with a warm temperature with pre-
cipitation, high temperatures have been noted to
affect the survival of fleas as well as vector-borne dis-
ease transmission [27]. Given the unusual growth
characteristics of R. felis requiring an optimal growth
temperature lower than that typical of other rickett-
siae at 28 °C [28], a link between Victoria and Tas-
mania with their moderate and cool temperate
climates and R. felis seropositivity is plausible.
Characterization of the epidemiology of FBSF has been
complicated by the wide-spread nature of incidental ex-
posure, compounded by a typically long-lived antibody
response and non-specific symptoms characteristic of
other fever-causing conditions [5]. It is clear from this
study that some of these veterinarians had been exposed
to R. felis in the past, but no veterinarians had reported
clinical symptoms matching the disease syndrome [5]
and none had been medically diagnosed. This is support-
ive of exposure being common but with a mild self-
resolving flu-like manifestation rather than severe clin-
ical FBSF [19, 20].
Older participants (aged 60+) had a 1.323 times lower
odds of exposure to R. felis (t = -2.095, P = 0.040; OR:
0.756; CI: 0.582–0.982), 1.202 times lower to R. typhi (t
= -1.93, P = 0.058; OR: 0.834, CI: 0.693–1.003), and 1.330
times lower to either R. felis or R. typhi (t = -2.147; P =
0.034; OR: 0.752; CI: 0.579–0.975) exposures, which is
consistent with the findings of Hidalgo et al. in a similar
study in Spain [21]. In our study, actively working older
participants spent less time (17.5 h) in private practice
compared with their younger and middle-aged counter-
parts (22 and 24 h, respectively). This lower clinical ex-
posure is likely reflected in the changing likelihood of
rickettsial exposure.
All five veterinarians who indicated that they did not
recommend flea-treatment to clients were positive to
rickettsial exposure (two to R. felis, three to indetermin-
ate exposure). This result is suggestive of a 1.637 times
reduction in odds of exposure to FBSF or MT for veteri-
narians that recommended their clients treat their pets
for fleas ( β = -0.493; SE = 0.242; t = -2.034; P = 0.044).
Attitudes towards regular flea prophylaxis may effect-
ively function as a reliable predictor for exposure to R.
felis with intrinsic ties to the potential for exposure of
the general population to flea-borne zoonoses from flea-
ridden pets and animals. A potential lack of awareness
of recent flea exposure and being bitten by a flea were
Table 2 Multivariate risk factor analysis of exposure to Rickettsia felis
Population Exposed Coefficient (SE) t P OR (95% CI)
Constant 0.111 (0.177) 0.625 0.534
Age
20–39 years 34 12 0.033 (0.112) 0.294 0.769 1.033 (0.83–1.286)
40–59 years 27 9 Reference
60+ years 17 0 -0.28 (0.134) -2.095 0.04 0.756 (0.582–0.982)
State
SA or WA 7 0 Reference
NSW or ACT 21 4 0.132 (0.185) 0.716 0.477 1.142 (0.794–1.641)
QLD 15 3 0.151 (0.194) 0.78 0.438 1.163 (0.796–1.699)
VIC or TAS 32 13 0.323 (0.179) 1.808 0.075 1.381 (0.973–1.96)
Abbreviations: CI confidence interval, OR odds ratio, SE standard error
Table 3 Multivariate risk factor analysis of exposure to Rickettsia typhi
Population Exposed Coefficient (SE) t P OR (95% CI)
Constant 0.182 (0.062) 2.923 0.005
Age
20–39 years 24 2 -0.098 (0.086) -1.144 0.257 0.906 (0.765–1.073)
40–59 years 22 4 Reference
60+ years 17 0 -0.182 (0.094) -1.93 0.058 0.834 (0.693–1.003)
Abbreviations: CI confidence interval, OR odds ratio, SE standard error
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also trends seen in the data, in which 29 Rickettsia exposed
participants reported with certainty that they had not been
recently bitten, highlighting that people may not realize that
they have been exposed to flea bites or inhaled flea feces [29]
and thus the zoonotic vector-borne organisms fleas harbor.
In our study, no statistically significant risk factors
were able to be linked between exposure to either R. felis
or R. typhi and contact with companion animals or with
fleas. This may be a reflection of the widespread, ubiqui-
tous exposure amongst the veterinary populace tested to
these factors (e.g. companion animals and the fleas asso-
ciated with them). There is an ongoing issue with R. felis
serology is cross-reactivity with TG rickettsiae (e.g. R.
typhi) antibodies [30] impeding acquisition of a defini-
tive serodiagnosis.
A validated protocol used for diagnostic testing [4] was
followed where serology was performed concurrently on
each sample tested against both R. felis and R. typhi, with
a positive result considered only when a sample tested
greater or equal to two serial dilutions (a four-fold in-
crease) of one antigen over the other. This ensured rigor
of the classification of the R. felis- and R. typhi-exposed
patients as high compared to previous serosurveys which
utilized protocols that used lower cut-off titers [31] whilst
being able to confidently classify the etiological agent [4].
Consequently, the number of participants testing positive
for an indeterminate rickettsial infection was produced. It
is likely that a proportion of these participants were only
exposed to either R. felis or R. typhi infections or alterna-
tively as mixed infections, where a patient may have been
exposed to both R. felis and R. typhi. An improvement in
the specificity of the test used (e.g. by using cross-
adsorption or Western blotting) may result in clearer data
on individual exposure status.
Conclusions
In Australia, veterinarians are considered at the forefront
of diagnosis, treatment and prevention of zoonotic dis-
eases from companion animals to their owners and the
general public. Given the low awareness of R. felis and
FBSF amongst our participants, improved education of
veterinarians and in turn pet owners is needed. In turn,
communication between medical, veterinary and diag-
nostic laboratory professions is also imperative for the
diagnosis and prevention of this common zoonosis. The
reported clinical cases of FBSF within the Australian
population [4] coupled with high exposure amongst vet-
erinary professionals suggests that FBSF is an important
cause of undifferentiated fever conditions that may not
be adequately recognized and potentially treated.
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